bioRxiv · 10.1101/2021.04.13.439702
CytoSet: Predicting clinical outcomes via set-modeling of cytometry data
Abstract
AO_SCPLOWBSTRACTC_SCPLOWSingle-cell flow and mass cytometry technologies are being increasingly applied in clinical settings, as they enable the simultaneous measurement of multiple proteins across millions of cells within a multi-patient cohort. In this work, we introduce CytoSet, a deep learning model that can directly predict a patients clinical outcome from a collection of cells obtained through a blood or tissue sample. Unlike previous work, CytoSet explicitly models the cells profiled in each patient sample as a set, allowing for the use of recently developed permutation invariant architectures. We show that CytoSet achieves state-of-the-art classification performance across a variety of flow and mass cytometry benchmark datasets. The strong classification performance is further complemented by demonstrated robustness to the number of sub-sampled cells per patient and the depth of model, enabling CytoSet to scale adequately to hundreds of patient samples. The strong performance achieved by the set-based architectures used in CytoSet suggests that clinical cytometry data can be appropriately interpreted and studied as sets. The code is publicly available at https://github.com/CompCy-lab/cytoset.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Yi, H., Stanley, N.. 2021-04-14. CytoSet: Predicting clinical outcomes via set-modeling of cytometry data. https://doi.org/10.1101/2021.04.13.439702
Cite the original work for its findings. Save a collection to share your selection of sources.